PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.48%
Negative revenue growth while 3391.T stands at 1.89%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.46%
Negative gross profit growth while 3391.T is at 2.27%. Joel Greenblatt would examine cost competitiveness or demand decline.
-24.95%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-28.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-25.47%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.47%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-25.47%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3391.T is at 0.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.07%
10Y revenue/share CAGR under 50% of 3391.T's 200.34%. Michael Burry would suspect a lasting competitive disadvantage.
64.73%
5Y revenue/share CAGR at 50-75% of 3391.T's 88.64%. Martin Whitman would worry about a lagging mid-term growth trajectory.
32.48%
3Y revenue/share CAGR at 50-75% of 3391.T's 49.61%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
126.36%
Below 50% of 3391.T's 256.92%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
101.74%
5Y net income/share CAGR 1.25-1.5x 3391.T's 76.62%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
77.60%
3Y net income/share CAGR above 1.5x 3391.T's 22.07%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
195.62%
10Y equity/share CAGR at 75-90% of 3391.T's 220.87%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
123.30%
5Y equity/share CAGR above 1.5x 3391.T's 69.31%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
57.64%
3Y equity/share CAGR 1.25-1.5x 3391.T's 39.02%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
266.67%
5Y dividend/share CAGR above 1.5x 3391.T's 89.77%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
144.44%
3Y dividend/share CAGR above 1.5x 3391.T's 19.29%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-3.70%
Firm’s AR is declining while 3391.T shows 1.17%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.46%
Inventory growth well above 3391.T's 4.39%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.01%
Negative asset growth while 3391.T invests at 0.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.68%
BV/share growth above 1.5x 3391.T's 2.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.56%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.60%
SG&A declining or stable vs. 3391.T's 7.63%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.